People with allergic conditions such as hay fever have a lower risk of being infected with COVID-19, a new study suggests.
Researchers from Queen Mary University of London looked at more than 16,000 adults in the UK between May 2020 and February 2021
They found that hay fever and eczema sufferers are nearly 25 percent less likely to contract the virus.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.